Danielle Thompson
Nurse Practitioner · Lock Haven, PANPI 1285178830
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 340 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 340 payments — averaging $16.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$938
- Lilly USA, LLC$488
- Amgen$316
- GSK$273
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$266
- plus $2K from 22 others
What the payments were for
- Food & beverage$5,465100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 83 | $1,283 |
| Novo Nordisk | 58 | $938 |
| Lilly USA, LLC | 34 | $488 |
| Amgen | 20 | $316 |
| GSK | 16 | $273 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 18 | $266 |
| Boehringer Ingelheim | 14 | $259 |
| Johnson & Johnson | 17 | $237 |
| Pfizer | 12 | $216 |
| Exact Sciences | 8 | $165 |
| AstraZeneca(2 entities) | 9 | $146 |
| Bayer | 5 | $106 |
| Phathom Pharmaceuticals, Inc. | 5 | $78 |
| Amarin Pharma, Inc. | 4 | $77 |
| E.r. Squibb & Sons, L.L.C. | 5 | $74 |
| Merck | 5 | $70 |
| Otsuka America Pharmaceutical, Inc. | 4 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $63 |
| Dexcom, Inc. | 3 | $62 |
| Medtronic | 2 | $44 |
| Biohaven Pharmaceuticals, Inc. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $37 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Sanofi-aventis U.S. LLC | 2 | $32 |
| Grifols USA, LLC | 2 | $31 |
| Philips North America LLC | 2 | $29 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $13 |
How this compares
$5,465 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 65 | $73,827 |
| JardianceEmpagliflozin | 46 | $58,875 |
| EliquisApixaban | 44 | $41,235 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 30 | $22,795 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 33 | $22,722 |
| OzempicSemaglutide | 14 | $18,717 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $11,080 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $10,770 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 12 | $4,349 |
| Incruse ElliptaUmeclidinium Bromide | 12 | $4,028 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 18 | $3,264 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 61 | $3,009 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 38 | $2,506 |
| Fentanyl | 17 | $1,946 |
| Atorvastatin Calcium | 97 | $1,666 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $488 | $73,82765 claims |
| Boehringer IngelheimJardiance | $259 | $58,87546 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $273 | $48,67475 claims |
| PfizerEliquis | $216 | $41,23544 claims |
| AstraZenecaBreztri Aerosphere | $146 | $22,72233 claims |
| Novo NordiskOzempic | $938 | $18,71714 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.
Other nurse practitioner in Lock Haven
- Patricia ManganPhiladelphia$360K
- Lisa CocoPhiladelphia$230K
- Elisabeth BaidalPhiladelphia$151K
- Suzanne McGettiganPhiladelphia$108K
- Tracey WileyChambersburg$101K
- Pamela LorditchJohnstown$81K
- Nana BernaskoHershey$81K
- Dawn JeanneratClarion$78K
- Carolyn GrandePhiladelphia$71K
- Nicole WaetzmanStrafford$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.